Harris Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-254,463
Closed -$23.1M 130
2018
Q4
$23.1M Sell
254,463
-3,487,394
-93% -$326M 0.05% 102
2018
Q3
$368M Sell
3,741,857
-130,517
-3% -$12.1M 0.58% 54
2018
Q2
$332M Sell
3,872,374
-122,499
-3% -$10.2M 0.54% 56
2018
Q1
$320M Sell
3,994,873
-10,169
-0.3% -$839K 0.54% 58
2017
Q4
$323M Buy
4,005,042
+870,868
+28% +$69.7M 0.53% 59
2017
Q3
$244M Sell
3,134,174
-44,156
-1% -$3.67M 0.41% 67
2017
Q2
$282M Sell
3,178,330
-11,881
-0.4% -$1M 0.51% 59
2017
Q1
$257M Buy
3,190,211
+802,452
+34% +$62.7M 0.47% 65
2016
Q4
$170M Buy
2,387,759
+556,092
+30% +$43.7M 0.33% 78
2016
Q3
$158M Sell
1,831,667
-1,670,081
-48% -$146M 0.31% 81
2016
Q2
$304M Sell
3,501,748
-152,536
-4% -$12.3M 0.61% 59
2016
Q1
$274M Sell
3,654,284
-2,734,063
-43% -$206M 0.52% 63
2015
Q4
$491M Sell
6,388,347
-585,195
-8% -$44.1M 0.83% 39
2015
Q3
$467M Sell
6,973,542
-405,790
-5% -$29.9M 0.82% 42
2015
Q2
$547M Sell
7,379,332
-3,955,016
-35% -$302M 0.87% 38
2015
Q1
$884M Sell
11,334,348
-372,842
-3% -$28.3M 1.4% 20
2014
Q4
$845M Sell
11,707,190
-1,629,445
-12% -$113M 1.31% 24
2014
Q3
$826M Buy
13,336,635
+259,417
+2% +$16.5M 1.36% 25
2014
Q2
$834M Sell
13,077,218
-330,605
-2% -$20.1M 1.4% 24
2014
Q1
$825M Buy
13,407,823
+440,135
+3% +$25.6M 1.48% 19
2013
Q4
$744M Buy
12,967,688
+192,478
+2% +$10.9M 1.33% 22
2013
Q3
$680M Buy
12,775,210
+130,219
+1% +$7.01M 1.32% 21
2013
Q2
$651M Buy
+12,644,991
New +$625M 1.37% 20

Other funds holding MDT

Harris Associates's MDT Position: Q1 2019 in Review

Harris Associates sold out of Medtronic (MDT) in Q1 2019, closing a stake of 254,463 shares — an estimated $23.1M sold.

Harris Associates first reported a position in MDT in Q2 2013 and held it in 23 quarters. The position peaked at $884M in Q1 2015. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • Harris Associates reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • Harris Associates sold 254,463 Medtronic shares in Q1 2019, an estimated $23.1M.
  • Harris Associates first reported a position in Medtronic in Q2 2013 and held it in 23 quarters.
  • Harris Associates's Medtronic position peaked at $884M in Q1 2015.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Harris Associates's 13F filing for Q1 2019, filed 15 May 2019.